ArticleStress biology2026
Plant viral suppressors HcPro and P19 inhibit CRISPR-Cas13-mediated transcript interference.
Article in Stress biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
RNA plays a central role in cellular dynamics, mediating the formation of proteins from genetic information. Thus, there is great interest in technologies that can alter RNA content of a cell to achieve desired outcomes. RNA targeting CRISPR‒Cas13 enables precise, sequence-guided targeting of RNA to disrupt translation and can therefore be used for cellular engineering. However, guide RNA from CRISPR systems can silence target transcripts independent of the Cas13 protein, complicating the deployment of CRISPR-Cas13 for biotechnology. To prevent Cas13-independent silencing and encourage Cas13-mediated transcript reduction, we explored the use of viral suppressors of RNAi. Here, we report that expression of two viral suppressors of RNAi, HcPro and P19, unexpectedly blocked Cas13-mediated transcript silencing in addition to Cas13-independent RNAi-like silencing. To further understand how HcPro blocks Cas13-mediated silencing, we expressed an RNA silencing-deficient HcPro mutant for RNA-targeting assays. The results demonstrate that mutant HcPro failed to suppress Cas13-dependent silencing, indicating that HcPro RNAi suppression also interferes with Cas13 silencing. These results suggest that plant viruses may be primed to overcome engineered CRISPR-Cas13 antiviral resistance through the activity of previously evolved RNAi silencing suppressors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.